Followers | 191 |
Posts | 32286 |
Boards Moderated | 7 |
Alias Born | 08/30/2018 |
Friday, July 16, 2021 1:30:17 PM
Recent STVN News
- Stevanato Group to Present at the Bank of America Securities Healthcare Conference • Business Wire • 05/01/2024 08:30:00 PM
- Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 04/25/2024 08:04:00 PM
- Stevanato Group appoints Ugo Gay as Chief Operations Officer • Business Wire • 04/04/2024 12:00:00 PM
- Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares • Business Wire • 03/26/2024 08:10:00 PM
- Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares • Business Wire • 03/22/2024 03:45:00 AM
- Stevanato Group Announces Public Offering of Ordinary Shares • Business Wire • 03/20/2024 09:12:00 PM
- Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum • Business Wire • 03/11/2024 09:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 09:00:15 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 09:00:07 PM
- Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023 • Business Wire • 03/07/2024 11:30:00 AM
- Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024 • Business Wire • 02/22/2024 09:30:00 PM
- Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization • Business Wire • 01/24/2024 01:00:00 PM
- Stevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/03/2024 09:30:00 PM
- Stevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma Manufacturing • Business Wire • 11/16/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/09/2023 09:00:03 PM
- Stevanato Group to Present at the Jefferies London Healthcare Conference • Business Wire • 11/09/2023 11:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2023 08:00:34 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/31/2023 03:58:26 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/31/2023 03:45:34 PM
- Stevanato Group Reports Third Quarter 2023 Financial Results • Business Wire • 10/31/2023 10:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/19/2023 08:30:57 PM
- Stevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023 • Business Wire • 10/17/2023 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/06/2023 09:29:59 PM
- Stevanato Group Announces Voting Results from its Extraordinary General Meeting • Business Wire • 10/05/2023 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/28/2023 01:31:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM